Allen, Wendy L <br/><br/>
Clinical determinants of response to irinotecan-based therapy derived from cell line models.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Oct 2008 
 - 6647-55 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-08-0452  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Camptothecin--analogs & derivatives<br/>Colorectal Neoplasms--drug therapy<br/>Drug Resistance, Neoplasm<br/>Gene Expression Profiling<br/>HCT116 Cells--drug effects<br/>Humans<br/>Irinotecan<br/>Oligonucleotide Array Sequence Analysis<br/>RNA, Messenger--genetics<br/>RNA, Neoplasm--genetics<br/>Retrospective Studies<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Topoisomerase I Inhibitors